Latest Headlines
-
Eli Lilly's New Texas Facility To Boost Small Molecule Production
9/23/2025
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines.
-
Groninger Acquires Isolator And Cleanroom OEM Reinraumtechnik Ulm
9/18/2025
With this strategic move, the family-owned company headquartered in Crailsheim not only expands its technological portfolio but also strengthens its expertise in a field that is crucial to the pharmaceutical industry: cleanroom and isolator technology.
-
GSK Commits $30B To U.S. R&D And Drug Manufacturing Expansion
9/17/2025
GSK plc (LSE/NYSE: GSK) today announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years.
-
Eli Lilly Announces Plans To Build New $5 Billion Drug Manufacturing Facility In Virginia
9/17/2025
Eli Lilly and Company (NYSE: LLY) today announced that it plans to build a $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County. The new site will be the company's first dedicated, fully integrated active pharmaceutical ingredient (API) and drug product facility for Lilly's emerging bioconjugate platform and monoclonal antibody portfolio.
-
CAI Appoints Jamie Robertson As Vice President Of Mission Critical To Drive Innovation And Operational Excellence Across Global Infrastructure Projects
9/14/2025
CAI, a global leader in operational readiness and excellence for high-stakes, regulated environments, is proud to announce the appointment of Jamie Robertson as Vice President of Mission Critical.
-
Körber To Exhibit Aseptic Processing, Packaging, Inspection And MES Software Technologies At Pack Expo 2025
9/11/2025
Körber, a major international technology group, invites media to visit its booth at Pack Expo 2025 in Las Vegas. This is a unique opportunity to discover how Körber is transforming entrepreneurial thinking into tangible customer success and shaping technological change.
-
Assets Of Sutro Biopharma To Be Auctioned – December 2025
9/11/2025
Late-model lab R&D and manufacturing equipment surplus to future needs of Sutro biopharma: spray dryer, chromatography systems, Westfalia separators, HPLCs & more.
-
Upperton Wins Pharma Contract Services Company Of The Year At The Pharma Industry Awards UK 2025
9/11/2025
Upperton Pharma Solutions has added another impressive award to a growing list of achievements, winning the award for Pharma Contract Services Company of the Year at the Pharma Industry Awards UK and nominated finalist for Pharma Company of the Year. This year marks a second year of success at the Pharma Industry Awards, with a win in 2024 for Large Pharma Project of the Year.
-
Results Of Nanoform Collaborative Study To Be Presented At U.S. Drug Delivery & Formulation (DDF) Summit
9/11/2025
Nanoform, a leading nanoparticle medicine performance-enhancing company, announced that key findings from two studies conducted in collaboration between Nanoform and Takeda will be presented at the 15th American Drug Delivery & Formulation Summit (DDF) in Boston, Mass., on September 16, 2025, at 09:10 – 09:40 in Room 1.
-
Ridge Biotechnologies Secures $25M Seed Funding To Pioneer AI-Powered Enzyme & Drug Design
9/11/2025
Ridge Biotechnologies (Ridge Bio), a company pioneering enzyme and targeted drug design to power the next wave of precision medicines, emerged from stealth today with an oversubscribed $25 million in seed financing. Sutter Hill Ventures (SHV) incubated Ridge Bio and led the round, with participation from Overlap Holdings among others.